Koshinski Asset Management, Inc.
Source: SEC Form 13F · as of Mar 2026Koshinski Asset Management, Inc. holds 19 biotech & pharma companies tracked by BioSniper, totaling $53.0M in value as of Mar 2026 (SEC Form 13F).
Companies held
19
Total value held
$53.0M
| Company | Shares | Value |
|---|---|---|
| JNJJOHNSON & JOHNSON | 83,440 | $20.4M |
| ABBVAbbVie Inc. | 34,069 | $7.4M |
| LLYELI LILLY & Co | 4,783 | $4.4M |
| AMGNAMGEN INC | 11,277 | $4.0M |
| PMPhilip Morris International Inc | 15,201 | $2.5M |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 8,997 | $2.4M |
| MCKMcKesson Corporation | 2,755 | $2.4M |
| ABTABBOTT LABORATORIES | 22,508 | $2.3M |
| PFEPFIZER INC | 53,829 | $1.5M |
| BMYBRISTOL MYERS SQUIBB CO | 22,288 | $1.4M |
| GILDGILEAD SCIENCES, INC. | 7,381 | $1.0M |
| AZNASTRAZENECA PLC | 4,719 | $931K |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 1,608 | $718K |
| DGXQuest Diagnostics Incorporated | 2,062 | $404K |
| NVONovo Nordisk A/S | 10,137 | $373K |
| NVSNovartis AG | 2,315 | $354K |
| OCSOculis Holding AG | 8,937 | $238K |
| MEDPMedpace Holdings Inc. | 482 | $231K |
| ANVSAnnovis Bio, Inc. | 15,028 | $34K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.